Pembrolizumab/nintedanibVarious toxicities: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1777卷 / 1期

关键词：

D O I：

10.1007/s40278-019-70779-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：196 / 196

相关论文

共 50 条

[21] Methylprednisolone/pembrolizumab/prednisoneVarious toxicities : case report
Reactions Weekly, 2024, 2028 (1) : 293 - 293
[22] Dabrafenib/pembrolizumab/trametinibVarious toxicities: case report
Reactions Weekly, 2025, 2043 (1) : 127 - 127
[23] Cisplatin/pembrolizumab/pemetrexedVarious toxicities and no response: case report
Reactions Weekly, 2021, 1858 (1) : 117 - 117
[24] Citalopram/gabapentin/pembrolizumab/topiramateVarious toxicities: case report
Reactions Weekly, 2020, 1809 (1) : 88 - 88
[25] Linagliptin/metformin/pembrolizumab interactionVarious toxicities: case report
Reactions Weekly, 2022, 1899 (1) : 228 - 228
[26] Carboplatin/pembrolizumab/pemetrexedMultiple toxicities: case report.
Reactions Weekly, 2020, 1834 (1) : 64 - 64
[27] Carboplatin/pembrolizumab/pemetrexed/olaparibVarious toxicities: case report
Reactions Weekly, 2022, 1930 (1) : 162 - 162
[28] Pembrolizumab/pyridostigmineVarious toxicities and drug ineffectiveness: case report
Reactions Weekly, 2021, 1859 (1) : 310 - 310
[29] Methylprednisolone/pembrolizumab/prednisoloneVarious toxicities and lack of efficacy: case report
Reactions Weekly, 2021, 1859 (1) : 228 - 228
[30] Dexamethasone/pembrolizumab/pemetrexedVarious toxicities and lack of efficacy: case report
Reactions Weekly, 2023, 1972 (1) : 143 - 143

← 1 2 3 4 5 →